NEW YORK (GenomeWeb News) — PerkinElmer today said it will help Johns Hopkins University and the University of Birmingham, UK, establish tools and technologies to discover diagnostic and therapeutic biomarkers in undisclosed indications.
 
PerkinElmer said it will use its BioExpression platform, a carrier protein-based biomarker enrichment technology that is used to find low-abundance disease-related biomarkers.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.